MyFinsight
Home
Blog
About
Cash and cash
equivalents
$196,576K
(164.26%↑ Y/Y)
Accounts receivable, net
$36,246K
(131.69%↑ Y/Y)
Inventory
$8,156K
(-36.54%↓ Y/Y)
Prepaid expenses and
other current assets
$4,022K
(-42.18%↓ Y/Y)
Other receivables
$506K
(-9.32%↓ Y/Y)
Total current assets
$245,506K
(122.39%↑ Y/Y)
Equity investments, at
fair value
$29,451K
Intangible assets, net
$25,510K
(-14.21%↓ Y/Y)
Operating lease
right-of-use asset, net
$11,357K
(-11.39%↓ Y/Y)
Property, plant and
equipment, net
$2,412K
(-10.80%↓ Y/Y)
Other assets
$1,259K
(-58.37%↓ Y/Y)
Restricted cash
$1,220K
(0.00%↑ Y/Y)
Total assets
$316,715K
(98.08%↑ Y/Y)
Total liabilities and
stockholders' equity
$316,715K
(98.08%↑ Y/Y)
Total stockholders'
equity
$206,086K
(451.28%↑ Y/Y)
Total liabilities
$110,629K
(-9.70%↓ Y/Y)
Total stockholders'
equity attributed to...
$164,140K
(273.69%↑ Y/Y)
Non-controlling interests
$41,946K
(741.28%↑ Y/Y)
Total current
liabilities
$62,018K
(7.82%↑ Y/Y)
Notes payable,
long-term
$34,602K
(-30.83%↓ Y/Y)
Operating lease
liabilities, long-term
$11,468K
(-13.79%↓ Y/Y)
Other long-term
liabilities
$2,541K
(52.89%↑ Y/Y)
Accumulated deficit
-$624,147K
(15.19%↑ Y/Y)
Additional
paid-in-capital
$788,251K
(1.08%↑ Y/Y)
Accounts payable and
accrued expenses
$49,325K
(1.54%↑ Y/Y)
Income taxes payable
$5,179K
(426.32%↑ Y/Y)
Partner company notes
payable, short-term
$5,000K
(33.33%↑ Y/Y)
Operating lease
liabilities, short-term
$2,246K
(4.95%↑ Y/Y)
Other current
liabilities
$268K
(-87.06%↓ Y/Y)
Common stock, 0.001 par
value, 200,000,000...
$33K
(10.00%↑ Y/Y)
Cumulative redeemable
perpetual preferred...
$3K
(0.00%↑ Y/Y)
Back
Back
Balance Sheet
Fortress Biotech, Inc. (FBIO)
Fortress Biotech, Inc. (FBIO)
source: myfinsight.com